Clinical Trial Update: Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring repurposed drug for prevention of chemotherapy-induced peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Snippet

Sponsor: Cairo University | Conditions: Chemotherapy-induced Peripheral Neuropathy | Phase 2 | Status: UNKNOWN